FlatCath formed to make vascular access products
This article was originally published in Clinica
A new company, FlatCath, is to be set up to develop and commercialise next-generaton vascular access products. The company is a joint venture between device incubator Hatch Medical and physician/inventor Aubrey Palestrant, who has four proprietary patents covering his technology.
You may also be interested in...
Moderna is pursuing a single-antigen strategy even though some of its mRNA vaccines have included multiple antigens; the SARS-CoV-2 spike protein likely provides the best antigen for developing immunity against the virus.
Latest warnings also include second and third businesses in US cannabidiol and hemp sector found making unlawful claims for treating and preventing COVID-19. Four of five firms warned apparently responded by removing violative claims from websites and social media posts.
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.